Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Multiple sclerosis: Bigger brains resist disability in MS.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.

Pages